logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • Mesenchymal stem cells regulate inflammation in patients with rheumatoid arthritis with multiple targets, providing new options for refractory patients
    2025-02-11
  • Union Medical College Hospital system analysis, 530 clinical trials, stem cell therapy is reshaping the treatment landscape of nervous system diseases
    2025-02-08
  • Sixteen types of mesenchymal stem cell drugs have been approved for marketing! Prices range from tens of thousands to hundreds of thousands of dollars!
    2025-02-07
  • The latest breakthrough in global pluripotent stem cell therapy in 2025:115 clinical trials reveal the future medical revolution
    2025-02-05
  • Life Sci | iPSC-derived MSCs: The angiogenesis ability is not as good as that of bone marrow MSCs, but it is more advantageous in cell therapy!
    2025-01-23
Prev
... 4 5 6 7 8 ...
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号